Publication:
Would a CYP2B6 test help HIV patients being treated with efavirenz?

Simple item page
dc.contributor.authorChonlaphat Sukasemen_US
dc.contributor.authorSomnuek Sungkanuparphen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T04:38:28Z
dc.date.available2018-10-19T04:38:28Z
dc.date.issued2013-07-01en_US
dc.identifier.citationPharmacogenomics. Vol.14, No.9 (2013), 999-1001en_US
dc.identifier.doi10.2217/pgs.13.69en_US
dc.identifier.issn17448042en_US
dc.identifier.issn14622416en_US
dc.identifier.other2-s2.0-84880469141en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/31283
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84880469141&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleWould a CYP2B6 test help HIV patients being treated with efavirenz?en_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84880469141&origin=inwarden_US

Files

Collections

Scopus 2011-2015